BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
Boehringer Ingelheim
Farmers Insurance
Medtronic
Deloitte
Chubb
Dow
US Department of Justice
Argus Health

Generated: January 21, 2018

DrugPatentWatch Database Preview

BAYCOL Drug Profile

« Back to Dashboard

When do Baycol patents expire, and when can generic versions of Baycol launch?

Baycol is a drug marketed by Bayer Pharms and is included in one NDA.

The generic ingredient in BAYCOL is cerivastatin sodium. Additional details are available on the cerivastatin sodium profile page.

US Patents and Regulatory Information for BAYCOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-001 Jun 26, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-004 Jun 26, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-002 Jun 26, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-003 Jun 26, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-006 Jul 24, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-005 May 24, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for BAYCOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-003 Jun 26, 1997 ➤ Subscribe ➤ Subscribe
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-006 Jul 24, 2000 ➤ Subscribe ➤ Subscribe
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-001 Jun 26, 1997 ➤ Subscribe ➤ Subscribe
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-004 Jun 26, 1997 ➤ Subscribe ➤ Subscribe
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-006 Jul 24, 2000 ➤ Subscribe ➤ Subscribe
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-001 Jun 26, 1997 ➤ Subscribe ➤ Subscribe
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-003 Jun 26, 1997 ➤ Subscribe ➤ Subscribe
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-002 Jun 26, 1997 ➤ Subscribe ➤ Subscribe
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-002 Jun 26, 1997 ➤ Subscribe ➤ Subscribe
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-005 May 24, 1999 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Argus Health
Mallinckrodt
Moodys
Baxter
Daiichi Sankyo
Accenture
Cipla
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot